Silke Schelenz

4.7k total citations · 2 hit papers
75 papers, 2.9k citations indexed

About

Silke Schelenz is a scholar working on Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Silke Schelenz has authored 75 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 43 papers in Epidemiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Silke Schelenz's work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers) and Cystic Fibrosis Research Advances (9 papers). Silke Schelenz is often cited by papers focused on Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (26 papers) and Cystic Fibrosis Research Advances (9 papers). Silke Schelenz collaborates with scholars based in United Kingdom, United States and Netherlands. Silke Schelenz's co-authors include Darius Armstrong‐James, Alireza Abdolrasouli, Elizabeth M. Johnson, Colin Brown, Andrew M. Borman, Jacques F. Meis, Anuradha Chowdhary, Matthew C. Fisher, Johanna Rhodes and Rohini Manuel and has published in prestigious journals such as Clinical Microbiology Reviews, Kidney International and Journal of Clinical Microbiology.

In The Last Decade

Silke Schelenz

66 papers receiving 2.8k citations

Hit Papers

First hospital outbreak of the globally emerging Candida ... 2016 2026 2019 2022 2016 2017 100 200 300 400 500

Peers

Silke Schelenz
Silke Schelenz
Citations per year, relative to Silke Schelenz Silke Schelenz (= 1×) peers Hiroshi Kakeya

Countries citing papers authored by Silke Schelenz

Since Specialization
Citations

This map shows the geographic impact of Silke Schelenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Schelenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Schelenz more than expected).

Fields of papers citing papers by Silke Schelenz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Schelenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Schelenz. The network helps show where Silke Schelenz may publish in the future.

Co-authorship network of co-authors of Silke Schelenz

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Schelenz. A scholar is included among the top collaborators of Silke Schelenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Schelenz. Silke Schelenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schelenz, Silke, Samir Agrawal, A. J. Brady, et al.. (2024). Antifungal stewardship in the UK: where are we now?. JAC-Antimicrobial Resistance. 7(1). dlae209–dlae209.
2.
Cooper, Margaret S., Agostino Cilibrizzi, Philip J. Blower, et al.. (2024). [68Ga]Ga-Schizokinen, a Potential Radiotracer for Selective Bacterial Infection Imaging. ACS Infectious Diseases. 10(8). 2615–2622. 2 indexed citations
3.
Logan, Clare, Carolyn Hemsley, A Fife, et al.. (2022). A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship. JAC-Antimicrobial Resistance. 4(3). dlac055–dlac055. 3 indexed citations
4.
Periselneris, Jimstan, Silke Schelenz, Michael R. Loebinger, et al.. (2021). Bronchiectasis severity correlates with outcome in patients with primary antibody deficiency. Thorax. 76(10). 1036–1039. 3 indexed citations
6.
Pringle, Edward, et al.. (2020). Correction: Care for critically ill patients with COVID-19: don’t forget the eyes. Eye. 35(4). 1285–1285. 1 indexed citations
7.
Cuthbertson, Leah, Phillip James, Michael J. Cox, et al.. (2020). The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis. Journal of Cystic Fibrosis. 20(2). 295–302. 42 indexed citations
8.
Kenters, Nikki, Martin Kiernan, Anuradha Chowdhary, et al.. (2019). Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. International Journal of Antimicrobial Agents. 54(4). 400–406. 78 indexed citations
9.
Ruiz, Gustavo Bravo, et al.. (2019). Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates. Current Genetics. 65(5). 1217–1228. 45 indexed citations
10.
Abdolrasouli, Alireza, Johanna Rhodes, Ferry Hagen, et al.. (2018). Airway persistence by the emerging multi‐azole‐resistant Rasamsonia argillacea complex in cystic fibrosis. Mycoses. 61(9). 665–673. 14 indexed citations
11.
Abdolrasouli, Alireza, Andrew Scourfield, Johanna Rhodes, et al.. (2018). High prevalence of triazole resistance in clinical Aspergillus fumigatus isolates in a specialist cardiothoracic centre. International Journal of Antimicrobial Agents. 52(5). 637–642. 37 indexed citations
12.
13.
Bidula, Stefan, Darren W. Sexton, Alireza Abdolrasouli, et al.. (2015). The Serum Opsonin L-ficolin Is Detected in Lungs of Human Transplant Recipients Following Fungal Infections and Modulates Inflammation and Killing ofAspergillus fumigatus. The Journal of Infectious Diseases. 212(2). 234–246. 41 indexed citations
14.
Schelenz, Silke, Rosemary A. Barnes, Richard C. Barton, et al.. (2015). British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. The Lancet Infectious Diseases. 15(4). 461–474. 130 indexed citations
15.
Bidula, Stefan, Darren W. Sexton, & Silke Schelenz. (2015). Serum opsonin ficolin-A enhances host–fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge. Medical Microbiology and Immunology. 205(2). 133–142. 17 indexed citations
16.
Schelenz, Silke, et al.. (2011). Epidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre. Annals of Oncology. 23(7). 1889–1893. 39 indexed citations
17.
Schelenz, Silke, et al.. (2010). Epidemiology of oral yeast colonization and infection in patients with hematological malignancies, head neck and solid tumors. Journal of Oral Pathology and Medicine. 40(1). 83–89. 74 indexed citations
18.
Vivancos, Roberto, Silke Schelenz, & Yoon K. Loke. (2007). Internet treatment of sexually transmitted infections – a public health hazard?. BMC Public Health. 7(1). 333–333. 13 indexed citations
19.
Doulton, Timothy, Hugh Cairns, Silke Schelenz, et al.. (2003). Infective endocarditis in dialysis patients: New challenges and old. Kidney International. 64(2). 720–727. 76 indexed citations
20.
Schelenz, Silke & W. R. Gransden. (2003). Candidaemia in a London teaching hospital: analysis of 128 cases over a 7‐year period. Mycoses. 46(9-10). 390–396. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026